Загрузка...

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

AIMS: Activation of PPARγ by pioglitazone (PIO) has shown some efficacy in attenuating addictive-like responses in laboratory animals. The ability of PIO to alter the effects of opioids in humans has not been characterized in a controlled laboratory setting. The proposed investigation sought to exam...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Physiol Behav
Главные авторы: Jones, Jermaine D., Sullivan, Maria A., Manubay, Jeanne M., Mogali, Shanthi, Metz, Verena E., Ciccocioppo, Roberto, Comer, Sandra D.
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444321/
https://ncbi.nlm.nih.gov/pubmed/26455893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2015.10.006
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!